Depressive Symptoms and Inflammatory Biomarkers in Patients with Heart Failure

Overview

Journal Eur J Cardiovasc Nurs

Publisher Oxford University Press

Specialties Cardiology & Vascular Diseases
Nursing

Date 2013 Sep 25

PMID 24062026

Citations 10

Authors

Rebecca L Dekker

Debra K Moser

Elizabeth G Tovar

Misook L Chung

Seongkum Heo

Jia Rong Wu

Sandra B Dunbar

Susan J Pressler

Terry A Lennie

Affiliations

Soon will be listed here.

Abstract

Background: Inflammation may be a link between depressive symptoms and outcomes in patients with heart failure. It is not clear whether inflammatory markers are independently related to depressive symptoms in this population.

Aim: To determine which inflammatory biomarkers are independently associated with depressive symptoms in heart failure.

Methods And Results: We analyzed data from 428 outpatients enrolled in a heart failure registry (32% female, 61 ± 12 years, 48% New York Heart Association Class III/IV). Depressive symptoms were measured with the Beck Depression Inventory-II. Serum C-reactive protein (CRP), cytokines (interleukin 1 receptor antagonist, 2, 4, 6, 8, 10), tumor necrosis alpha, and soluble receptors sTNFR1 and sTNFR2 were measured with enzyme immunoassay. Multiple regressions were used to determine which biomarkers were associated with depressive symptoms controlling for demographics, heart failure severity, and clinical variables. Twenty-seven percent (n = 119) had depressive symptoms. CRP was related to depressive symptoms after controlling for age and gender, but no inflammatory biomarkers were associated with depressive symptoms after controlling for all variables in the model.

Conclusions: There was no relationship between inflammatory biomarkers and depressive symptoms. Our findings, in combination with prior researchers', suggest there is not a robust relationship between depressive symptoms and individual biomarkers of inflammation in heart failure.

Citing Articles

Correlation of Sociodemographic Factors, Characteristics of Burns, and Neutrophil-to-Lymphocyte Ratio with the Level of Depression in Patients with Burn injuries.

Soedjana H, Hasibuan L, Riestiano B, Andayani S, Nurfitriani A, Sundoro A JPRAS Open. 2024; 40:346-355.

PMID: 38756416 PMC: 11096802. DOI: 10.1016/j.jpra.2024.04.005.

Impact of a Stress Reduction, Meditation, and Mindfulness Program in Patients with Chronic Heart Failure: A Randomized Controlled Trial.

Cavalcante V, Mesquita E, Cavalcanti A, Miranda J, Jardim P, Bandeira G Arq Bras Cardiol. 2023; 120(10):e20220768.

PMID: 37909602 PMC: 10586813. DOI: 10.36660/abc.20220768.

Heart failure symptom burden, dietary intake, and inflammation: An integrative review of the literature.

Davis E, Dunbar S, Higgins M, Wood K, Ferranti E, Morris A J Integr Nurs. 2023; 5(2):81-92.

PMID: 37727310 PMC: 10508190. DOI: 10.4103/jin.jin_26_23.

Changes of inflammatory and oxidative stress biomarkers in dogs with different stages of heart failure.

Rubio C, Saril A, Kocaturk M, Tanaka R, Koch J, Ceron J BMC Vet Res. 2020; 16(1):433.

PMID: 33167963 PMC: 7654180. DOI: 10.1186/s12917-020-02650-7.

Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis.

Leighton S, Nerurkar L, Krishnadas R, Johnman C, Graham G, Cavanagh J Mol Psychiatry. 2017; 23(1):48-58.

PMID: 29133955 PMC: 5754468. DOI: 10.1038/mp.2017.205.

References

Kupper N, Widdershoven J, Pedersen S . Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patients. J Affect Disord. 2011; 136(3):567-76. DOI: 10.1016/j.jad.2011.10.029. View

Whisman M, Perez J, Ramel W . Factor structure of the Beck Depression Inventory-Second Edition (BDI-II) in a student sample. J Clin Psychol. 2000; 56(4):545-51. DOI: 10.1002/(sici)1097-4679(200004)56:4<545::aid-jclp7>3.0.co;2-u. View

Bozkurt B, Mann D, Deswal A . Biomarkers of inflammation in heart failure. Heart Fail Rev. 2009; 15(4):331-41. DOI: 10.1007/s10741-009-9140-3. View

Riegel B, Moser D, Glaser D, Carlson B, Deaton C, Armola R . The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nurs Res. 2002; 51(4):209-18. DOI: 10.1097/00006199-200207000-00001. View

Riegel B, Moser D, Rayens M, Carlson B, Pressler S, Shively M . Ethnic differences in quality of life in persons with heart failure. J Card Fail. 2008; 14(1):41-7. DOI: 10.1016/j.cardfail.2007.09.008. View

Howren M, Lamkin D, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71(2):171-86. DOI: 10.1097/PSY.0b013e3181907c1b. View

Pasic J, Levy W, Sullivan M . Cytokines in depression and heart failure. Psychosom Med. 2003; 65(2):181-93. DOI: 10.1097/01.psy.0000058372.50240.38. View

Lakoski S, Cushman M, Criqui M, Rundek T, Blumenthal R, DAgostino Jr R . Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J. 2006; 152(3):593-8. DOI: 10.1016/j.ahj.2006.02.015. View

Johansson P, Lesman-Leegte I, Svensson E, Voors A, Van Veldhuisen D, Jaarsma T . Depressive symptoms and inflammation in patients hospitalized for heart failure. Am Heart J. 2011; 161(6):1053-9. DOI: 10.1016/j.ahj.2011.03.011. View

10.

Orus J, Roig E, Perez-Villa F, Pare C, Azqueta M, Filella X . Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant. 2000; 19(5):419-25. DOI: 10.1016/s1053-2498(00)00083-8. View

11.

Kop W, Synowski S, Gottlieb S . Depression in heart failure: biobehavioral mechanisms. Heart Fail Clin. 2010; 7(1):23-38. DOI: 10.1016/j.hfc.2010.08.011. View

12.

Wirtz P, Redwine L, Linke S, Hong S, Rutledge T, Greenberg B . Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients. Brain Behav Immun. 2009; 24(3):366-9. DOI: 10.1016/j.bbi.2009.02.004. View

13.

Ferketich A, Ferguson J, Binkley P . Depressive symptoms and inflammation among heart failure patients. Am Heart J. 2005; 150(1):132-6. DOI: 10.1016/j.ahj.2004.08.029. View

14.

Parissis J, Adamopoulos S, Rigas A, Kostakis G, Karatzas D, Venetsanou K . Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol. 2004; 94(10):1326-8. DOI: 10.1016/j.amjcard.2004.07.127. View

15.

Grothe K, Dutton G, Jones G, Bodenlos J, Ancona M, Brantley P . Validation of the Beck Depression Inventory-II in a low-income African American sample of medical outpatients. Psychol Assess. 2005; 17(1):110-4. DOI: 10.1037/1040-3590.17.1.110. View

16.

Redwine L, Mills P, Hong S, Rutledge T, Reis V, Maisel A . Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom Med. 2007; 69(1):23-9. DOI: 10.1097/PSY.0b013e31802e2f35. View

17.

Katz J, Chang L, Sangha O, Fossel A, Bates D . Can comorbidity be measured by questionnaire rather than medical record review?. Med Care. 1996; 34(1):73-84. DOI: 10.1097/00005650-199601000-00006. View

18.

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

19.

Woloshin S, Schwartz L . Distribution of C-reactive protein values in the United States. N Engl J Med. 2005; 352(15):1611-3. DOI: 10.1056/NEJM200504143521525. View

20.

Rauchhaus M, Doehner W, Francis D, Davos C, Kemp M, Liebenthal C . Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000; 102(25):3060-7. DOI: 10.1161/01.cir.102.25.3060. View